000 | 01952 a2200577 4500 | ||
---|---|---|---|
005 | 20250517061612.0 | ||
264 | 0 | _c20160620 | |
008 | 201606s 0 0 eng d | ||
022 | _a1873-2623 | ||
024 | 7 |
_a10.1016/j.transproceed.2015.09.025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Sousa-Amorim, E | |
245 | 0 | 0 |
_aDesensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study. _h[electronic resource] |
260 |
_bTransplantation proceedings _cOct 2015 |
||
300 |
_a2332-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
650 | 0 | 4 |
_aDesensitization, Immunologic _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 |
_aGraft Survival _ximmunology |
650 | 0 | 4 |
_aHLA Antigens _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aKidney Failure, Chronic _ximmunology |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 | _aLiving Donors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
650 | 0 | 4 | _aPlasmapheresis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRituximab _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aRevuelta, I | |
700 | 1 | _aBlasco, M | |
700 | 1 | _aDiekmann, F | |
700 | 1 | _aCid, J | |
700 | 1 | _aLozano, M | |
700 | 1 | _aSánchez-Escuredo, A | |
700 | 1 | _aMartorell, J | |
700 | 1 | _aPalou, E | |
700 | 1 | _aCampistol, J M | |
700 | 1 | _aOppenheimer, F | |
773 | 0 |
_tTransplantation proceedings _gvol. 47 _gno. 8 _gp. 2332-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2015.09.025 _zAvailable from publisher's website |
999 |
_c25404183 _d25404183 |